gadolinium chloride has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, JH; Buehler, PW; Ferguson, SK; Fini, MA; Harral, JW; Hassell, K; Irwin, DC; Karoor, V; Moldova, R; Nozik-Grayck, E; Nuss, R; Pak, D; Palmer, AF; Redinus, K; Shin, HKH; Stenmark, KR; Swindle, D; Yalamanoglu, A | 1 |
| Belcastro, R; Copland, I; Frndova, H; Hoidal, JR; Jankov, RP; Luo, X; Lye, SJ; Post, M; Tanswell, AK | 1 |
2 other study(ies) available for gadolinium chloride and Pulmonary Hypertension
| Article | Year |
|---|---|
An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Disease Progression; Gadolinium; Hemoglobins; Humans; Hypertension, Pulmonary; Hypoxia; Macrophages; Male; Pulmonary Artery; Rats; Vascular Remodeling | 2019 |
Gadolinium chloride inhibits pulmonary macrophage influx and prevents O(2)-induced pulmonary hypertension in the neonatal rat.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Cell Movement; Cells, Cultured; Dinoprost; Endothelin-1; F2-Isoprostanes; Gadolinium; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infant, Newborn; Macrophages, Alveolar; Oxygen; Rats; Rats, Sprague-Dawley; Tyrosine | 2001 |